Moderna | MRNA - Sales Revenues

Stock Price
55.74
Daily Change
3.22 6.13%
Monthly
32.73%
Yearly
55.01%
Q1 Forecast
50.93

Moderna reported $678M in Sales Revenues for its fiscal quarter ending in December of 2025.





Sales Change Date
Acadia Pharmaceuticals USD 284M 5.4M Dec/2025
Agios Pharmaceuticals USD 19.97M 7.07M Dec/2025
Alnylam Pharmaceuticals USD 1.1B 150M Dec/2025
Amgen USD 9.9B 340M Dec/2025
Arrowhead Research USD 264.03M 7.56M Dec/2025
Biogen USD 2.28B 250M Dec/2025
BioMarin Pharmaceutical USD 875M 99M Dec/2025
Celltrion KRW 1.33T 300B Mar/2026
Cspc Pharmaceutical CNY 6.62B 358.95M Sep/2025
Deva Holding AS TRY 2.32B 418.58M Sep/2023
Dianthus Therapeutics USD 396K 203K Sep/2025
Divis Laboratories Ltd INR 26.04B 1.11B Dec/2025
Esperion Therapeutics USD 51.63M 22.2M Sep/2024
Gilead Sciences USD 7.93B 130M Dec/2025
GlaxoSmithKline GBP 8.62B 73M Dec/2025
Incyte USD 1.51B 140M Dec/2025
Ionis Pharmaceuticals USD 203M 46M Dec/2025
Kangmei Pharma CNY 1.37B 101.16M Sep/2025
Knight Therapeutics CAD 92.26M 3.31M Sep/2024
Laboratorios Farma EUR 448.66M 67.82M Dec/2023
Moderna USD 678M 342M Dec/2025
Organigram Holdings CAD 80.06M 9.27M Sep/2025
Pharma Mar EUR 90.2M 54.5M Dec/2025
Puma Biotechnology USD 80.54M 33.46M Sep/2024
Qiagen NV USD 457.38M 6.06M Dec/2025
Regeneron Pharmaceuticals USD 3.88B 130M Dec/2025
Sangamo BioSciences USD 356K 125K Jun/2024
Sarepta Therapeutics USD 442.9M 43.5M Dec/2025
Sartorius EUR 927.6M 84.4M Dec/2025
Sino Biopharmaceutical CNY 17.57B 4.58B Jun/2025
Tilray USD 217.51M 74.75M Dec/2025
Ultragenyx Pharmaceutical USD 207M 47M Dec/2025
United Therapeutics USD 790.2M 9.3M Dec/2025
Vertex Pharmaceuticals USD 3.19B 110M Dec/2025
Zhangzhou Pientzehuang Pharmaceutical CNY 2.88B 642.99M Sep/2025